A new study at Massachusetts Eye and Ear showed that in some cases of vestibular schwannoma, a sometimes-lethal tumor often associated with neurofibromatosis 2 (NF2), secretions from the tumor contain ...

Removing a vestibular schwannoma - a slow-growing, benign tumor that develops in the nerves connecting the inner ear to the brain - is a delicate procedure. Surgeons must differentiate the tumor from ...

Neurofibromatosis type 2 (NF2) is an autosomal‐dominant disorder characterised by the development of multiple tumours, most notably bilateral vestibular schwannomas. These benign tumours originate ...

Salicylates, a class of non-steroidal inflammatory drugs (NSAIDs), reduced the proliferation and viability of cultured vestibular schwannoma cells that cause a sometimes lethal intracranial tumor that ...

Radiotherapy was effective in controlling growing vestibular schwannomas over 10 years, regardless of pretreatment tumor size or location. Compared with previous, small studies, these results offer “a ...

image: Researchers from Massachusetts Eye and Ear and the Harvard Medical School/ Massachusetts Institute of Technology's Program in Speech and Hearing Bioscience and Technology have demonstrated that ...

A new understanding of the pathobiology behind a head and neck tumor has been uncovered that may someday lead to new methods of targeted drug therapy, scientists report. Researchers from the ...

April 18, 2023 –Vestibular schwannomas related to neurofibromatosis type 2 (NF2) are difficult to manage and are sometimes treated with a noninvasive option, stereotactic radiosurgery. A retrospective ...

Losartan, a popular medication used to treat hypertension, could improve hearing in patients who developed hearing loss due to vestibular schwannoma (VS). Researchers from the Massachusetts General ...

Vestibular schwannoma (VS), a tumor that occurs sporadically or in association with neurofibromatosis type 2, presents with sensorineural hearing loss (SNHL) in the majority of patients. Previous ...

Mumbai: Dr Satish Nair, Senior Consultant, ENT & Head and Neck Oncology, Apollo Cancer Centre, Bangalore, spoke to ETHealthworld’s Prabhat Prakash about the endoscopic trans canal excision of facial ...